Skip to content

Emmanuel S Onaivi

3 papers in the library · 36 citations · publishing 1998-2002

Papers

Sort Most recent Most cited

Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation.

Annals of the New York Academy of Sciences June 1, 2002 Emmanuel S Onaivi, Syed F. Ali, Sanika S Chirwa et al. 23 citations

The mapping of the human genetic code will enable us to identify potential gene products involved in human addictions and diseases that have hereditary components. Thus, large-scale, parallel gene-expression studies, made possible by advances in microarray technologies, have shown insights into the connection between specific genes, or sets of genes, and human diseases. The compulsive use of...

Endocannabinoids and cannabinoid receptor genetics.

Progress in Neurobiology April 2002 Emmanuel S Onaivi, Claire M Leonard, Hiroki Ishiguro et al.

This review presents the remarkable advances that have been achieved in marijuana (cannabinoid) research, with the discovery of specific receptors and the existence of naturally occurring cannabis-like substances in the human body and brain. The last decade has seen more rapid progress in marijuana research than any time in the thousands of years that marijuana has been used by humans,...

In Vivo Ibogaine Blockade and In Vitro PKC Action of Cocainea.

Annals of the New York Academy of Sciences May 1, 1998 Emmanuel S Onaivi, Syed F. Ali, Amitabha Chakrabarti 13 citations

Ibogaine may have antiaddiction potential against alcohol, psychostimulant and opiate abuse, but its mechanism of action is unclear. Ibogaine, however, has been demonstrated in numerous studies to have effects in multiple central nervous system (CNS) neurotransmitters systems. We are using in vitro and in vivo systems to study the effects of cocaine and whether these effects can be blocked by...